Photo by nci from unsplash
Background: Novel oral anti-coagulation therapies (NOAC) have now become the standard of care treatment among patients at risk of stroke with non-valvular atrial fibrillation (AF) in the US. NOAC use… Click to show full abstract
Background: Novel oral anti-coagulation therapies (NOAC) have now become the standard of care treatment among patients at risk of stroke with non-valvular atrial fibrillation (AF) in the US. NOAC use has significantly increased since the first therapies were launched in late 2010. This paper
Keywords:
atrial fibrillation;
fibrillation;
noacs versus;
versus warfarin;
warfarin use
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of the American College of Cardiology
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!